Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Tax Provisions (2022 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Tax Provisions for 4 consecutive years, with -$4000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions changed 0.0% year-over-year to -$4000.0, compared with a TTM value of -$217000.0 through Jun 2025, down 116.12%, and an annual FY2024 reading of -$4000.0, down 100.22% over the prior year.
  • Tax Provisions was -$4000.0 for Q4 2025 at Arcturus Therapeutics Holdings, down from $4000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $893000.0 in Q3 2023 and bottomed at -$217000.0 in Q3 2024.
  • Average Tax Provisions over 4 years is $172909.1, with a median of $100000.0 recorded in 2022.
  • Peak annual rise in Tax Provisions hit 268.0% in 2024, while the deepest fall reached 126.0% in 2024.
  • Year by year, Tax Provisions stood at $100000.0 in 2022, then surged by 135.0% to $235000.0 in 2023, then plummeted by 101.7% to -$4000.0 in 2024, then changed by 0.0% to -$4000.0 in 2025.
  • Business Quant data shows Tax Provisions for ARCT at -$4000.0 in Q4 2025, $4000.0 in Q2 2025, and -$4000.0 in Q4 2024.